IASLC
LightNews LightNews
banner
iaslc.bsky.social
IASLC
@iaslc.bsky.social
520 followers 11 following 170 posts
International Association for the Study of Lung Cancer
Posts Replies Media Videos
iaslc.bsky.social
The IASLC @ascocancer.bsky.social North American Conference on Lung Cancer is underway!

Researchers are rolling out new data, from breakthroughs in early-stage treatment to new insights on immunotherapy & tough-to-treat #lungcancer subtypes.

bit.ly/4pjQ2ZE

#NACLC2025 #CancerResearch
Key Data and Big Debates to Watch for at the North American Conference on Lung Cancer
Cutting-edge research, vigorous debates, and a healthy dose of humor and collegiality are all on tap for the 2025 North American Conference on Lung Cancer, which will be held in Chicago, Dec. 5–9.
bit.ly
December 5, 2025 at 5:33 PM
iaslc.bsky.social
New episode! 🎧
Host @stephenvliu.bsky.social talks with Prof. Li Zhang and Dr. Elaine Shum about how ADCs are reshaping treatment for EGFR-mutant NSCLC, from new approvals to next-gen agents on the horizon.

Listen here: bit.ly/3XyFycL

#LungCancer #NSCLC #EGFR #ADCs #CancerResearch
December 3, 2025 at 7:23 PM
iaslc.bsky.social
The IASLC | @ascocancer.bsky.social 2025 NACLC is coming soon!

This year’s program brings together global experts for high-impact debates, real-world case discussions, and collaborative networking designed to spark new ideas and advance patient care.

Save 20% with code CHICAGO20.
➡️ bit.ly/4oL1rl4
November 25, 2025 at 10:30 PM
iaslc.bsky.social
Help IASLC continue advancing lung cancer research and advocacy by considering a donation today. bit.ly/4nBZ6HU
November 24, 2025 at 8:53 PM
iaslc.bsky.social
🧬New data presented by Dr. Nan Bi shed light on ctDNA status to identify patients who would benefit from consolidation ICI.

Learn more in ILCN: bit.ly/3XaZ1Ab
Using Early ctDNA, Study Findings Inform Prognostic Model - ILCN.org (ILCN/WCLC)
New data presented by Dr. Nan Bi shed new light on ctDNA status to identify patients who would benefit from consolidation ICI and to predict survival outcomes.
bit.ly
November 24, 2025 at 2:07 AM
Reposted by IASLC
oncodaily.bsky.social
Inside “IASLC 2025 Hot Topic in Basic and Translational Science” with Triparna Sen

@triparnasen.bsky.social @iaslc.bsky.social

oncodaily.com/voices/iaslc...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews
Inside “IASLC 2025 Hot Topic in Basic and Translational Science” with Triparna Sen - OncoDaily
Inside “IASLC 2025 Hot Topic in Basic and Translational Science” with Triparna Sen / cancer, HT25, IASLC 2025, IASLC 2025 Hot Topic, IASLC HT25, International
oncodaily.com
November 23, 2025 at 1:40 AM
iaslc.bsky.social
New evidence strengthens the connection between air pollution exposure and higher #lungcancer risk.

Emerging data highlights the urgent need to address environmental factors that impact lung health.

Read the full story on ILCN: bit.ly/4ooeJ6g

#LCSM #LungCancerAwarenessMonth
New Data Strengthen the Link Between Air Pollution Exposure and Increased Lung Cancer Risk - ILCN.org (ILCN/WCLC)
Researchers addressed the role of PM2.5 in lung cancer initiation and screening outcomes, as well as how genetic and air pollution scores can identify those at an increased risk.
www.ilcn.org
November 23, 2025 at 1:24 AM
iaslc.bsky.social
⏳ Only 3 weeks left!
Join us at the IASLC | @ascocancer.bsky.social 2025 North America Conference on Lung Cancer, featuring expert debates, case discussions, and expanded networking.

Use code CHICAGO20 for 20% off in-person registration.

Register now: bit.ly/4oL1rl4
November 21, 2025 at 12:17 AM
iaslc.bsky.social
NEW! IASLC has launched the beta version of VIKTOR, a new tool from the Basic & Translational Science Committee designed to bring all digital knowledge on preclinical models into one accessible, reliable hub.

Learn more about VIKTOR: bit.ly/4pm6b0A

#LCSM #LCAM
IASLC Launches Beta Version of VIKTOR - ILCN.org (ILCN/WCLC)
The Basic and Translational Science Committee’s new tool aims to unify available digital knowledge about preclinical models into one accessible, reliable system.
www.ilcn.org
November 19, 2025 at 8:21 PM
iaslc.bsky.social
Annabelle Gurwitch's story as a #lungcancer survivor shows the power of early detection. Stand with IASLC to strengthen lung health worldwide 🫁.
Every contribution helps drive research and hope.
Donate this LCAM: bit.ly/47M76Bx
November 17, 2025 at 10:15 PM
iaslc.bsky.social
There's still time to take the survey! ⬇️
iaslc.bsky.social IASLC @iaslc.bsky.social · 26d
Help shape how patient experiences are measured in #lungcancer #research. 🫁

IASLC invites you to review and share feedback on consensus statements about patient-reported outcomes (PROMs) in early-stage and radically treated lung cancer trials.

📋 Take the short #survey here: bit.ly/3Jzdl2f
November 17, 2025 at 6:43 PM
iaslc.bsky.social
Curious why biomarker timing matters in NSCLC treatment? For Cancer Biomarker Awareness Day, check out this past Lung Cancer Considered discussion: bit.ly/489wK2Z
#biomarkertesting
The Importance of Waiting for Biomarker Results in NSCLC | IASLC
Biomarkers are essential in lung cancer treatment, but they remain underutilized. In addition, clinicians and patients have to wait for those results before sta ...
bit.ly
November 14, 2025 at 12:11 AM
iaslc.bsky.social
#WCLC2025 recap: STAS is associated with poor prognosis in early-stage NSCLC, regardless of surgical approach.
Read the latest data from Dr. Yasushi Yatabe in ILCN: bit.ly/4nl8ijw

#LCSM
STAS is Associated with Poor Prognosis in Early-Stage NSCLC Regardless of Surgical Approach - ILCN.org (ILCN/WCLC)
JCOG0802/WJOG4607L data validate segmentectomy as non-inferior to lobectomy, regardless of the presence of STAS, Dr. Yasushi Yatabe said.
bit.ly
November 12, 2025 at 5:03 PM
iaslc.bsky.social
Help shape how patient experiences are measured in #lungcancer #research. 🫁

IASLC invites you to review and share feedback on consensus statements about patient-reported outcomes (PROMs) in early-stage and radically treated lung cancer trials.

📋 Take the short #survey here: bit.ly/3Jzdl2f
November 10, 2025 at 4:37 PM
Reposted by IASLC
oncodaily.bsky.social
Narjust Florez Empowers Cancer Advocates’ Stories During Lung Cancer Awareness Month – IASLC

@narjustflorezmd.bsky.social @iaslc.bsky.social

oncodaily.com/voices/narju...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews
Narjust Florez Empowers Cancer Advocates' Stories During Lung Cancer Awareness Month – IASLC - OncoDaily
Narjust Florez Empowers Cancer Advocates' Stories During Lung Cancer Awareness Month – IASLC / cancer, IASLC, Lung cancer, lung cancer awareness month,
oncodaily.com
November 7, 2025 at 9:49 PM
iaslc.bsky.social
In this #LungCancerConsidered episode, Dr. Elene Mariamidze speaks with Dr. Salome Begijanashvili, Dr. Beka Shubitidze & Dr. Mariam Tchiabrishvili in Georgian about the most impactful #WCLC25 data and clinical updates.

Listen now: bit.ly/WCLC25Georgian #Georgia #Georgian
LCC in Georgian: WCLC 2025 Highlights | IASLC
The 2025 World Conference on Lung Cancer brings together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer resear ...
bit.ly
November 7, 2025 at 6:25 PM
iaslc.bsky.social
Looking to grow your thoracic oncology career?

The IASLC Academy connects you with global mentors, builds your research & communication skills, and opens doors worldwide.

Apply by Nov 10 to join the 2026 cohort! bit.ly/3WFQjty
November 5, 2025 at 9:23 PM
iaslc.bsky.social
Every story shared during #LungCancerAwarenessMonth helps break stigma and build understanding.

In this #LungCancerConsidered episode, Dr. Bryant Lin shares his journey as both a doctor and patient with stage IV lung cancer.

Listen now: bit.ly/47ybmmI
Interview with Dr. Bryant Lin: Teaching My Lung Cancer | IASLC
In this episode of Lung Cancer Considered, host Dr. Stephen Liu speaks with Dr. Bryant Lin, Clinical Professor of Medicine at Stanford University and co-founder ...
bit.ly
November 3, 2025 at 10:39 PM
iaslc.bsky.social
It’s Lung Cancer Awareness Month 💙. Research improves outcomes for the world’s deadliest cancer. The IASLC community works to conquer lung cancer every day. Help fund critical research and make an impact: https://bit.ly/4nBZ6HU
November 1, 2025 at 5:01 PM
iaslc.bsky.social
Don’t miss out, early-bird registration for TTLC 2026 ends today!
Join global experts in lung cancer targeted therapies this February in Huntington Beach, CA.
Submit your abstract by Nov 18 to share your research.
Register now and submit your abstract: https://bit.ly/4393xm6

#TTLC2026 #LungCancer
October 31, 2025 at 6:18 PM
iaslc.bsky.social
The IASLC | @ascocancer.bsky.social NACLC conference is back and more interactive than ever!
✅ Lively debates
✅ Early-career networking
✅ 20% off with code CHICAGO20
✅ On-demand access available

Join us to connect, learn, and lead in #lungcancer care.
Register now: bit.ly/3JpX2oo
#NACLC #Oncology
October 31, 2025 at 12:07 AM
iaslc.bsky.social
At #WCLC2025, patient advocate Debra Montague unveiled new survey data showing serious communication challenges in lung cancer care.
Full story in ILCN: https://bit.ly/48MyLD8
#LCSM
Lost in Translation: Survey Reveals Critical Communication Gaps in Lung Cancer Care - ILCN.org (ILCN/WCLC)
Complex information and poor communication were identified as major obstacles to meaningful participation in decision-making, according to data presented by patient advocate Debra Montague.
bit.ly
October 28, 2025 at 2:54 PM
iaslc.bsky.social
Thoracic Circle is your space to connect, collaborate, and grow within the IASLC community. 🌐
Join the conversation today: http://bit.ly/3JnsOCb

#IASLC #ThoracicCircle #LungCancer
October 27, 2025 at 1:20 PM
iaslc.bsky.social
#WCLC25 recap: Dr. Jessica J. Lin explains how the ECOG-ACRIN E4512 results won't change clinical practice. Read why in a new ILCN article: http://bit.ly/3W1SPdd #lungcancer #research
Lessons from ECOG-ACRIN E4512: Could Limited Gains Lead to Positive Direction in Refining Adjuvant Therapy? - ILCN.org (ILCN/WCLC)
Discussant Dr. Jessica L. Lin said the results won't change clinical practice after Dr. David Gerber reported no differences in OS or DFS.
bit.ly
October 26, 2025 at 7:25 PM
iaslc.bsky.social
In this Japanese-language episode, Dr. Misako Nagasaka moderates a discussion with @hhorinouchi.bsky.social on highlights from #WCLC25, including FLAURA2 and HARMONi.

Listen to their insights on emerging lung cancer treatment: http://bit.ly/3Jl3Cwi

#LungCancer #Oncology #IASLC
LCC in Japanese: WCLC 2025 Highlights | IASLC
The 2025 World Conference on Lung Cancer brings together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer resear ...
bit.ly
October 25, 2025 at 3:20 PM